In pharmaceutical and biotechnology innovation patent litigation is not merely a legal hurdle; it is a multi-million-dollar crucible where market […]

Welcome. If you’re a professional in the pharmaceutical and biotech space, you understand that the conversation about generic drugs goes

Introduction The branded pharmaceutical industry, long a bastion of high-margin innovation, stands at a precipice. It is caught in the

Introduction: The 20-Year Illusion and the Race for Effective Patent Life In pharmaceutical innovation the 20-year patent term is both

The market value of a pharmaceutical company is the discounted sum of its future cash flows, and those cash flows

Pharmaceteutical stock valuation is an exercise in probabilistic accounting. Traditional financial metrics fail because they are retrospective. A price-to-earnings (P/E)

The pharmaceutical industry operates within a dual-track reality where the brilliance of molecular engineering is frequently secondary to the structural

In pharmaceutical patent litigation, the 180-day generic drug exclusivity is the ultimate prize. It is the “brass ring” 1, a

From Lagging Indicators to Leading Signals: The Strategic Imperative of Alternative Data For decades, investment decisions in the pharmaceutical and